Intercerebral implantation of allogenic CD34+ stem cell
DMR97-IRB-178-4
Phase 1 other active
Quick answer
Intercerebral implantation of allogenic CD34+ stem cell for Ischemic Stroke is a Phase 1 program (other) at Hospital Authority, Hong Kong with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Hospital Authority, Hong Kong
- Indication
- Ischemic Stroke
- Phase
- Phase 1
- Modality
- other
- Status
- active